Average real variability (ARV) is a recently proposed index for shortterm blood pressure (BP) variability. We aimed to determine the minimum number of BP readings required to compute ARV without loss of prognostic information.
Average real variability (ARV) is a recently proposed index to represent short-term, reading-to-reading, within-subject variability in blood pressure (BP). 1 ARV attempts to correct for the limitations of the commonly used standard deviation (SD), which accounts only for the dispersion of values around the mean, and not for the order of the BP readings. [1] [2] [3] Several recent studies reported on the association between cardiovascular outcome and BP variability as assessed by 24-hour ambulatory BP monitoring. 1, 2, [4] [5] [6] Most of these studies included a small (n < 350) general 1, 6 or hypertensive population 5 with a high percentage (>70%) of valid BP readings obtained at intervals ranging from 15 1, 5 to 30 4, 6 minutes during daytime and from 30 1, 5 to 60 4, 6 minutes during nighttime. Participants with fewer than 32, 6 57, 1 or 59 5 BP readings during the 24-hour monitoring period were excluded from these studies. e study with the largest number of participants (n = 8,938), taken from the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes (IDACO), 7 excluded subjects that had less than 10 daytime or 5 nighttime BP readings or missing BP measurements during 3 consecutive hours. 2 However, none of the aforementioned studies considered the minimum number of BP readings required to estimate BP variability in an accurate manner. e aim of our study was to use a dataset of 1,254 IDACO subjects with at least 80 ambulatory BP readings to determine an adequate number of BP readings needed to calculate ARV. We took advantage of the prospective design of IDACO to determine such number based on outcome data. e results were then validated using a test dataset with a larger number of subjects.
METHODS

Study population
At the time of writing this report, the IDACO database included 12,722 participants from 12 randomly recruited population cohorts. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] e Copenhagen cohort, 8, 18, 19 for which ambulatory BP was recorded at 15-minute intervals from 7:00 to 11:00 , and at 30-minute intervals from 11:00 to 7:00 , was selected as the discovery dataset for this study. e Copenhagen cohort included 2,311 subjects equally distributed among the 2 sexes and among 4 age groups (41, 51, 61, and 71 years). Subjects with incomplete ambulatory BP recordings (<80 readings during 24 hours) were excluded (n = 1,057), leaving 1,254 subjects for the discovery analysis. e results were tested for prognostic accuracy, using a larger sample of IDACO participants (test dataset). e test dataset included 5,353 IDACO subjects, who (i) were at least 18 years old, (ii) had at least 10 daytime readings, 5 nighttime readings, and 48 readings over 24 hours, and (iii) were not included in the discovery dataset.
BP measurement
A detailed description of the methods employed for conventional and ambulatory BP monitoring is provided in the Supplementary Data. Hypertension was de ned as a conventional BP of at least 140 mm Hg systolic or 90 mm Hg diastolic, or the use of antihypertensive drugs. 20 e devices used in IDACO all passed validation and were programmed to obtain readings at 30-minute intervals throughout the whole day, or at intervals ranging 15-30 minutes during daytime and 30-60 minutes at night. Within individual subjects, the means of the ambulatory BP were weighted by the interval between readings. ARV over 24 hours was calculated using the following formula:
where n is the number of BP readings and w k is the time interval between BP k and BP k-1 . 1,2
Ascertainment of events
We ascertained vital status and the incidence of fatal and nonfatal diseases from the appropriate sources in each country, as described in previous publications. 1, 7, 9, 12, 13, 15 Fatal and nonfatal stroke did not include transient ischemic attacks. Cardiac events encompassed death from ischemic heart disease, sudden death, fatal and nonfatal heart failure, nonfatal myocardial infarction, and coronary revascularization. e composite cardiovascular endpoint included all aforementioned endpoints plus cardiovascular mortality. In all outcome analyses, we only considered the rst event within each category. e cardiovascular endpoints and the International Classi cation of Disease code numbers used to di erentiate the events are available in Supplementary Table S1 .
Statistical analysis
For database management and statistical analyses, we used SAS so ware, version 9.1.3 (SAS Institute, North Carolina, USA) and MATLAB so ware, version R2009a (MathWorks, Massachusetts, USA). Statistical signi cance was α < 0.05 on 2-tailed tests. For comparison of means and proportions, we applied the large-sample z test and the χ 2 statistic, respectively. In the discovery dataset, we randomly excluded 8, 16, 24, 32, 40 , and 48 BP readings from each full ambulatory recording, generating reduced recordings with 72, 64, 56, 48, 40, and 32 readings. Each reduction was based on the original full recording and used a di erent random seed. In an attempt to approximate the e ect of missed readings, we did not eliminate BP measurements during the rst or last hour of the ambulatory readings, and we did not eliminate more than 4 consecutive daytime or 2 consecutive nighttime readings. We quanti ed concordance between ARV calculated from full and reduced recordings using Pearson's correlation coe cient, repeatability, and relative repeatability coe cients. [21] [22] [23] e repeatability coe cient was de ned as twice the SD of the within-subject di erence between ARV calculated from full and reduced recordings. e relative repeatability coe cient was the repeatability coe cient expressed as a percentage of the maximal variability (4 times the SD of ARV averaged across the full and reduced recordings). Higher values of repeatability and relative repeatability coe cients indicate lower concordance. We used the Cox proportional hazard regression model to compute standardized hazard ratios (HRs), which express the risk for an increase by 1 SD in the independent variables. e HRs in the discovery dataset were initially computed adjusting only for sex and age, the most signicant independent cardiovascular predictors for this cohort (P < 0.001), because the original Copenhagen Cohort was sampled with stratifying for sex and 4 age groups. e prognostic information contributed by ARV based on reduced recordings was considered accurate if the standardized HR remained signi cant (P ≤ 0.05) and ≥1.10. We plotted the 10-year risk (expressed as a percentage) of all-cause mortality and the composite cardiovascular endpoint in relation to ARV calculated from full and reduced recordings, standardized to the mean distribution of sex and age in the discovery dataset. In the test dataset, further adjustments were applied for cohort, body mass index, serum cholesterol, smoking status, alcohol intake, history of cardiovascular disease, and treatment with antihypertensive drugs. Additionally, in fully adjusted models, we accounted for 24-hour BP. Finally, we calculated the generalized R 2 , which is a measure for the re nement of the risk prediction by adding covariables to the Cox model. 24 Hypertension was a conventional blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic or use of antihypertensive drugs. All between-sex differences were significant (P < 0.05) with the exception of smoking (P = 0.13), age (P = 0.63), prevalence of hypertension (P = 0.07) and diabetes mellitus (P = 0.13), and 24-hour systolic average real variability (P = 0.32) in the discovery dataset and serum cholesterol (P = 0.33) and prevalence of antihypertensive drug intake (P = 0.3) in the test dataset.
RESULTS
Discovery
at Columbia University on August 17, 2013 http://ajh.oxfordjournals.org/ Downloaded from revascularization, 15 deaths from ischemic heart disease, 5 sudden deaths, 46 nonfatal heart failures, 8 fatal heart failures, 4 deaths from peripheral arterial disease, and 3 unspeci ed cardiovascular deaths.
e median number of BP readings in the discovery dataset was 81 (5th-95th percentile = 80-84). In general, mean ARV increased with decreasing number of BP measurements. In addition, the repeatability and relative repeatability coe cients increased, and Pearson correlation coe cients decreased with fewer BP readings, indicating reduced concordance with ARV based on full recordings as more readings were excluded (Table 2) .
When the full recordings were used, the sex-and ageadjusted HRs associated with an increase in systolic ARV by 1 SD were 1.18 (95% con dence interval (CI) = 1.04-1.33; P = 0.01) for total mortality and 1.20 (95% CI = 1.04-1.39; P = 0.01) for the composite cardiovascular endpoint. For diastolic BP, these HRs were 1.16 (95% CI = 1.02-1.32; P = 0.02) and 1.15 (95% CI = 0.99-1.33; P = 0.07). In general, reducing the number of BP readings led to smaller HRs (Tables  3 and 4 ; Figure 1 ) and, consequently, a weaker association between the 10-year risk and ARV (Figures 2 and 3) . However, the HRs remained fairly constant down to 40-48 BP readings. For total mortality, the HRs associated with both Abbreviations: ARV, average real variability over 24 hours; Delta, ARV based on reduced recording minus ARV based on full recording (at least 80 measurements); NA, not applicable; RC, repeatability coefficient for the correspondence between the reduced and full recordings; RRC, relative repeatability coefficient for the correspondence between the full and reduced recordings. .01 mm Hg, respectively. All hazard ratios were computed by Cox regression and were adjusted for sex and age. Delta is the percent difference between the hazard ratio calculated from the reduced recording and the hazard ratio calculated from the full recording.
Abbreviation: NA, not applicable. Significance of the hazard ratios: *P < 0.01; **P < 0.05; ***0.05 ≤ P < 0.10. .01 mm Hg, respectively. All hazard ratios were computed by Cox regression and were adjusted for sex and age. Delta is the percent difference between the hazard ratio calculated from the reduced recording and the hazard ratio calculated from the full recording.
Abbreviation: NA, not applicable. Significance of the hazard ratios: *P < 0.0001; **P < 0.001; ***P < 0.05; ****0.05 ≤ P < 0.10.
at Columbia University on August 17, 2013 http://ajh.oxfordjournals.org/ Downloaded from systolic and diastolic ARV were signi cant (P < 0.05) and >10% when ARV was calculated with at least 48 BP readings. Similarly, for the composite cardiovascular endpoint, reduced recordings composed of at least 48 readings generally yielded HRs ≥1.10 for both systolic and diastolic ARV. However, for systolic ARV statistical signi cance was lost when <56 readings were used. For diastolic ARV, the HRs were not signi cant either for the full or reduced recordings. The analyses were standardized to the midpoint (mean or ratio) of the distributions in the discovery cohort of sex and age. P values are for the independent e ect of ARV calculated from full (P 80 ) and reduced (P 72 , P 64 , P 56 , P 48 , P 40 , and P 32 ) recordings. The analyses were standardized to the midpoint (mean or ratio) of the distributions in the discovery cohort of sex and age. P values are for the independent e ect of ARV calculated from full (P 80 ) and reduced (P 72 , P 64 , P 56 , P 48 , P 40 , and P 32 ) recordings.
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Test dataset
e results based on arti cially reduced ambulatory BP recordings were con rmed using a larger sample of 5,353 subjects, whose ambulatory BP recordings included at least 48 BP readings. e test dataset included 879 residents of Copenhagen, Denmark, who were not included in the discovery dataset; 8 954 subjects from Noorderkempen, Belgium; 17 925 older men from Uppsala, Sweden; 9 242 subjects from Novosibirsk, the Russian Federation; 10,11 422 inhabitants of Ohasama, Japan; 15 344 villagers from JingNing County, China; 12 161 subjects from Pilsen, the Czech Republic; 11 265 subjects from Dublin, Ireland; 14 310 subjects from Padova, Italy; 11 308 subjects from Kraków, Poland; 11 and 543 older subjects from Maracaibo, Venezuela. 13 Compared with the discovery dataset, the 2,440 women and 2,913 men included in the test dataset were younger (54.0 ± 16.1 years) and had lower body mass index (25.6 ± 4.1 kg/m 2 ) and lower 24-hour ambulatory BP (125.1 ± 14.5 mm Hg systolic, 73.8 ± 8.4 mm Hg diastolic). e test dataset included a similar proportion of hypertensive patients (47.5%) but more subjects receiving antihypertensive drug treatment (21.3%). e test dataset included smaller proportions of smokers (27.6%) and subjects reporting alcohol intake (54.0%) and a higher proportion of subjects with a history of cardiovascular disease (16.2%) or diabetes mellitus (7.3%). e median number of BP readings per recording in the test dataset was 64 (5th-95th percentile = 48-79).
Median follow-up for participants in the test dataset was e cause of death was cardiovascular in 335 participants. Considering causespeci c rst cardiovascular events, the incidences of fatal and nonfatal stroke were 39 and 200, respectively. Cardiac events consisted of 172 fatal and 265 nonfatal events, including 143 nonfatal cases of acute myocardial infarction, 155 deaths from ischemic heart diseases, 6 sudden deaths, 11 fatal and 84 nonfatal cases of heart failure, and 38 cases of surgical or percutaneous coronary revascularization.
e standardized HRs relating outcome to ARV, adjusted for cohort, sex, age, body mass index, smoking status, alcohol intake, serum cholesterol, history of cardiovascular disease, and treatment with antihypertensive drugs, showed that systolic and diastolic ARV signi cantly (P < 0.0005) predicted total, cardiovascular, and cardiac mortality and fatal plus nonfatal cardiovascular and cerebrovascular events (Table 5 ). Systolic but not diastolic ARV also signi cantly (P = 0.003) predicted cardiac events. However, a er additional adjustment for 24-hour mean BP, systolic and diastolic ARV signi cantly (P < 0.01) predicted only total, cardiovascular, and cardiac deaths. In addition, higher diastolic ARV was signi cantly (P = 0.009) related to the incidence of fatal plus nonfatal cerebrovascular outcomes. e R 2 statistics for adding ARV to BP level and other covariables as combined predictors of the composite cardiovascular endpoint were 0.035% and 0.031% for systolic and diastolic ARV, respectively (Supplementary Table S2 ) DISCUSSION e technique of noninvasive ambulatory BP monitoring has rapidly expanded during the past 30 years, both as an instrument in clinical research and as a diagnostic tool in clinical practice. Several studies have examined the e ect of intermittent readings on the accurate assessment of true 24-hour average BP. 23, [25] [26] [27] Despite numerous studies that have reported on the predictive value of short-term BP variability, 1,2,5,28,29 the frequency and/or number of BP readings necessary to accurately estimate variability of 24-hour BP has not been assessed before. Di Rienzo et al. 25 demonstrated that accurate estimation of 24-hour average BP could be achieved at intervals as great as 30-60 minutes; however, short-term BP variability at sampling intervals of ≥15 minutes, as assessed by within-subject SD, deviated considerably from beat-to-beat analysis.
Several studies found that both short-term reading-toreading 23, [25] [26] [27] and long-term visit-to-visit [30] [31] [32] [33] BP variability, estimated by ambulatory BP monitoring, are poorly reproducible, which could explain the rather diverse ndings regarding its clinical value as a predictor of cardiovascular outcomes. 34 Several factors are potentiality responsible for the poor reproducibility of BP variability. First, it could be in uenced by day-to-day variation in the subject's activities. Second, predictions could have been based on insu cient numbers of BP readings; a small sample size increases the potential error in estimating the true variance. 25 Finally, although the SD is a convenient measure, it might not be the most accurate method to assess BP variability. [1] [2] [3] 5, 30 To address the latter 2 problems, in the present IDACO study, BP variability was assessed using ARV, 1,2 and the number of BP readings needed to make accurate risk predictions was formally tested. e most important observation was that the number of BP readings used to calculate ARV a ected both its reproducibility and its strength as a predictor of mortality and cardiovascular outcomes. Concordance between ARV values based on full and randomly reduced BP measurements and predictive value declined signi cantly as more BP readings were excluded. A possible explanation is that within-subject ARV might increase when calculated from fewer BP readings, masking di erences between subjects that actually have high or low BP variability.
In a discovery dataset that included >1,000 randomly recruited subjects with a median of 12.4 years of follow-up, a minimum of approximately 48 BP readings was necessary to accurately estimate ARV. is conclusion was supported using a test dataset with >5,000 subjects, randomly recruited from 11 populations, with a median of 10.2 years of follow-up. Using this minimum number of BP readings, both systolic and diastolic ARV were signi cant predictors of mortality and cardiovascular endpoints in models adjusted for 24-hour BP level and other covariables. ese results are in partial agreement with those of Hansen et al., 2 who computed ARV with a less restrictive minimum number of BP readings (at least 10 daytime and 5 nighttime BP readings). ey found that both systolic ARV and diastolic ARV were signi cant and independent predictors of total and cardiovascular mortality and of fatal combined with nonfatal cardiovascular events. However, this study did not nd that ARV was a signi cant and independent predictor of cardiac mortality in a fully adjusted model. 2 Although prognostic value 1,2,5 and reproducibility 30 are better for ARV than for other variability indexes, such as SD or weighted SD, 35 ARV computed with at least 48 BP readings accounted for <0.1% of risk of a composite cardiovascular event, beyond the proportion explained by 24-hour BP level. Furthermore, although the precision of ARV could be improved by increasing the number of measurements, increasing the number of BP readings beyond 48 readings in clinical practice seems inconvenient, because this makes 24-hour ambulatory BP monitoring less comfortable.
erefore, accurate assessment of BP variability might have greater relevance for research than for clinical purposes. It could produce unconfounded information on mechanisms of homeostatic control of BP under physiological and pathological conditions, such as essential and secondary hypertension, congestive heart failure, diabetes, and renal insu ciency. A reliable assessment of BP variability, with an adequate minimum number of BP readings could also be used to design studies to improve the diagnosis and prognosis of hypertension by providing better information on end-point organ damage associated with high BP values and could be used to assess the e cacy of antihypertensive agents. 36 Finally, accurate calculation of ARV could be useful in the development of therapeutic drugs to reduce BP variability, which might represent a new strategy for the treatment of hypertension. 37 Despite the statistical power and the consideration of fatal and nonfatal events, this study had several potential limitations. First, although the test dataset was composed of 11 population-based cohorts from 3 continents, our results might not be applicable to all ethnic groups, particularly to Africans of black ancestry or African Americans, although Veerabhadrappa et al. 6 showed that ARV was signi cantly Values are standardized hazard ratios (HRs) (95% confidence intervals (CIs)) associated with 1 SD increase in average real variability (ARV) calculated using at least 48 readings. The SD of the ARV was 3.32 mm Hg for systolic blood pressure and 2.66 mm Hg for diastolic blood pressure. All HRs were computed by Cox regression, stratified for cohort, and adjusted for sex, age, body mass index, smoking status, alcohol intake, serum cholesterol, history of cardiovascular disease, and treatment with antihypertensive drugs. Fully adjusted models were additionally adjusted for the 24-hour blood pressure level.
Significance of the hazard ratios: *P < 0.0001; **P < 0.001; ***P < 0.01. is number of BP readings should be considered for research purposes when trying to assess the e ects of BP variability on outcome variables or the e ects of an intervention on BP variability using ARV as an estimate. Usefulness of ARV in the clinical setting remains to be determined, but ARV needs to be computed with enough measurements to retain its prognostic value.
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